Replimune Group (REPL) Earnings Date, Estimates & Call Transcripts → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free REPL Stock Alerts $5.10 +0.09 (+1.80%) (As of 05/30/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueREPL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.REPL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchGet out of dollars—get into America’s new money insteadIs America's New Money right for you? I can't say... but I do know it's 100% legal and available to everyone... although precious few know much about it.Everything you need to know is posted on our website here. Replimune Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.87)($0.80)($0.84)Q2 20242($0.96)($0.80)($0.88)Q3 20242($0.90)($0.85)($0.88)Q4 20243($1.01)($0.74)($0.91)FY 20249($3.74)($3.19)($3.50)Q1 20253($0.85)($0.77)($0.82)Q2 20253($0.83)($0.79)($0.81)Q3 20253($0.84)($0.75)($0.80)Q4 20253($0.88)($0.70)($0.81)FY 202512($3.40)($3.01)($3.24)Q1 20261($0.91)($0.91)($0.91)Q2 20261($0.76)($0.76)($0.76)Q3 20261($0.78)($0.78)($0.78)Q4 20261($0.61)($0.61)($0.61)FY 20264($3.06)($3.06)($3.06) Get Replimune Group Earnings AlertsEnter your email address below to receive the latest news and earnings results for REPL and its competitors with MarketBeat's FREE daily newsletter. REPL Earnings Date and InformationReplimune Group has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Replimune Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 2/8/2024Q3 2024($0.89)($0.77)+$0.12($0.77)-- 11/7/2023Q2 2024($0.80)($0.90)($0.10)($0.90)-- 8/3/2023Q1 2024($0.80)($0.75)+$0.05($0.75)-- 5/18/2023Q4 2023($0.66)($0.74)($0.08)($0.74)--2/9/2023Q3 2023($0.77)($0.69)+$0.08($0.69)--11/3/2022Q2 2023($0.78)($0.79)($0.01)($0.79)-- Get the Latest News and Ratings for REPL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Replimune Group and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q1 2023($0.63)($0.78)($0.15)($0.78)--5/19/2022Q4 2022($0.60)($0.60)-($0.60)--2/3/2022Q3 2022($0.58)($0.57)+$0.01($0.57)--11/4/2021Q3 2021($0.51)($0.56)($0.05)($0.56)--8/6/2021Q2 2021($0.44)($0.53)($0.09)($0.53)--5/20/2021Q1 2021($0.41)($0.41)-($0.41)--2/4/2021Q4 2020($0.41)($0.44)($0.03)($0.44)--11/5/2020Q3 2020($0.43)($0.46)($0.03)($0.46)-- 8/7/2020Q2 2020($0.44)($0.44)-($0.44)--6/3/2020Q1 2020($0.45)($0.41)+$0.04($0.41)--2/13/2020Q3($0.3620)($0.46)($0.0980)($0.46)--11/11/2019Q2 2020($0.3410)($0.35)($0.0090)($0.35)--8/14/2019Q1 2020($0.3150)($0.30)+$0.0150($0.30)--6/28/2019Q4 2019($0.35)($0.15)+$0.20($0.15)-- Replimune Group Earnings - Frequently Asked Questions When is Replimune Group's earnings date? Replimune Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on REPL's earnings history. How much profit does Replimune Group generate each year? Replimune Group (NASDAQ:REPL) has a recorded net income of -$215.79 million. REPL has generated -$3.24 earnings per share over the last four quarters. What is Replimune Group's EPS forecast for next year? Replimune Group's earnings are expected to grow from ($3.25) per share to ($2.59) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Jasper Therapeutics Earnings Date Aura Biosciences Earnings Date MeiraGTx Earnings Date Tenaya Therapeutics Earnings Date Tourmaline Bio Earnings Date Candel Therapeutics Earnings Date Anavex Life Sciences Earnings Date Sutro Biopharma Earnings Date SOPHiA GENETICS Earnings Date Poseida Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Abercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the Dip This page (NASDAQ:REPL) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 MediaGet out of dollars—get into America’s new money insteadStansberry ResearchThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Replimune Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.